United States Antimony Financials

UAMY

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 72/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

United States Antimony has an operating margin of -16.0%, meaning the company retains $-16 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -81.3% the prior year.

Growth

100

United States Antimony's revenue surged 71.8% year-over-year to $14.9M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

100

United States Antimony carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 5.16, United States Antimony holds $5.16 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

United States Antimony has a free cash flow margin of 12.0%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.

Piotroski F-Score Neutral

5/9

United States Antimony passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-1.28x

For every $1 of reported earnings, United States Antimony generates $-1.28 in operating cash flow ($2.2M OCF vs -$1.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

This page shows United States Antimony (UAMY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$14.9M

YoY+71.8%

5Y CAGR+12.6%

10Y CAGR+3.3%

United States Antimony generated $14.9M in revenue in fiscal year 2024. This represents an increase of 71.8% from the prior year.

EBITDA

-$1.3M

YoY+78.6%

United States Antimony's EBITDA was -$1.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 78.6% from the prior year.

Free Cash Flow

$1.8M

YoY+128.5%

United States Antimony generated $1.8M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 128.5% from the prior year.

Net Income

-$1.7M

YoY+72.7%

United States Antimony reported -$1.7M in net income in fiscal year 2024. This represents an increase of 72.7% from the prior year.

EPS (Diluted)

$-0.02

YoY+66.7%

United States Antimony earned $-0.02 per diluted share (EPS) in fiscal year 2024. This represents an increase of 66.7% from the prior year.

Cash & Debt

$18.2M

YoY+52.7%

5Y CAGR+153.7%

10Y CAGR+64.7%

United States Antimony held $18.2M in cash against $195K in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

113M

YoY+4.9%

5Y CAGR+10.1%

10Y CAGR+5.5%

United States Antimony had 113M shares outstanding in fiscal year 2024. This represents an increase of 4.9% from the prior year.

Gross Margin

23.2%

YoY+61.7pp

5Y CAGR+33.1pp

10Y CAGR+26.4pp

United States Antimony's gross margin was 23.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 61.7 percentage points from the prior year.

Operating Margin

-16.0%

YoY+65.3pp

5Y CAGR+29.4pp

10Y CAGR-1.3pp

United States Antimony's operating margin was -16.0% in fiscal year 2024, reflecting core business profitability. This is up 65.3 percentage points from the prior year.

Net Margin

-11.6%

YoY+61.4pp

5Y CAGR+32.8pp

10Y CAGR+3.2pp

United States Antimony's net profit margin was -11.6% in fiscal year 2024, showing the share of revenue converted to profit. This is up 61.4 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$431K

YoY-71.8%

5Y CAGR-11.5%

10Y CAGR-13.5%

United States Antimony invested $431K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 71.8% from the prior year.

UAMY Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$14.9M+71.8%	$8.7M-21.3%	$11.0M+42.6%	$7.7M+48.0%	$5.2M-36.7%	$8.3M
Cost of Revenue	$11.5M-4.7%	$12.0M+33.0%	$9.0M+31.0%	$6.9M+37.4%	$5.0M-44.6%	$9.1M
Gross Profit	$3.5M+203.7%	-$3.3M-267.6%	$2.0M+138.0%	$839K+307.7%	$206K+125.2%	-$816K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.1M+25.0%	$1.6M+149.5%	$658K-2.9%	$678K+11.6%	$607K-10.0%	$674K
Operating Income	-$2.4M+66.2%	-$7.1M-2130.1%	$348K+152.7%	-$660K+80.0%	-$3.3M+12.0%	-$3.8M
Interest Expense	N/A	N/A	$15K+173.4%	$6K-69.2%	$18K-77.0%	$78K
Income Tax	$0	$0-100.0%	$16K	$0	$0	$0
Net Income	-$1.7M+72.7%	-$6.3M-1581.0%	$429K+808.9%	-$60K+98.2%	-$3.3M+10.5%	-$3.7M
EPS (Diluted)	$-0.02+66.7%	$-0.06	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$8.7M-17.3%	$10.5M+50.4%	$7.0M+24.3%	$5.6M+53.7%	$3.7M+19.2%	$3.1M+42.6%	$2.2M+4.4%	$2.1M
Cost of Revenue	$6.7M-13.0%	$7.7M+66.1%	$4.6M+4.5%	$4.4M+83.5%	$2.4M-2.8%	$2.5M-62.0%	$6.5M+262.2%	$1.8M
Gross Profit	$2.0M-29.0%	$2.8M+19.6%	$2.4M+97.1%	$1.2M-3.7%	$1.3M+112.1%	$589K+113.4%	-$4.4M-1796.8%	$258K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$883K+4.7%	$843K+53.1%	$551K+25.5%	$439K-12.7%	$503K+0.5%	$500K-48.1%	$964K+232.2%	$290K
Operating Income	-$4.9M-24677.3%	$20K-94.4%	$358K+133.0%	-$1.1M-2037.8%	$56K+111.9%	-$470K+92.9%	-$6.6M-1711.2%	-$364K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$4.8M-2733.2%	$182K-66.8%	$547K+161.9%	-$883K-535.4%	$203K+162.8%	-$323K+90.9%	-$3.6M-116.5%	-$1.6M
EPS (Diluted)	$-0.04	N/A	$0.00+100.0%	$-1000000.00-200.0%	$1000000.00	$0.00+100.0%	$-1000000.00-200.0%	$1000000.00

UAMY Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$34.6M+23.3%	$28.1M-19.0%	$34.7M-0.9%	$35.0M+163.2%	$13.3M-2.9%	$13.7M
Current Assets	$20.7M+46.9%	$14.1M-34.9%	$21.6M-8.3%	$23.6M+1203.5%	$1.8M+41.3%	$1.3M
Cash & Equivalents	$18.2M+52.7%	$11.9M-37.6%	$19.1M-10.8%	$21.4M+2857.3%	$722K+318.1%	$173K
Inventory	$1.2M-10.1%	$1.4M+0.8%	$1.4M+30.3%	$1.1M+62.3%	$650K+3.8%	$626K
Accounts Receivable	$1.1M+75.9%	$625K-20.3%	$784K-12.0%	$891K+273.5%	$239K-16.1%	$284K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$6.0M+134.7%	$2.6M-9.1%	$2.8M+7.5%	$2.6M-56.9%	$6.1M+17.0%	$5.2M
Current Liabilities	$4.0M+346.4%	$897K-59.6%	$2.2M+7.2%	$2.1M-53.8%	$4.5M+12.6%	$4.0M
Long-Term Debt	$195K	$0-100.0%	$218K+1.3%	$215K+527.2%	$34K-55.3%	$77K
Total Equity	$28.6M+12.1%	$25.5M-19.9%	$31.9M-1.5%	$32.4M+350.4%	$7.2M-15.1%	$8.5M
Retained Earnings	-$41.1M-4.4%	-$39.4M-19.2%	-$33.1M-1.1%	-$32.7M-0.2%	-$32.7M-11.2%	-$29.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$79.9M+68.2%	$47.5M+20.3%	$39.5M+14.0%	$34.6M+19.7%	$28.9M+3.3%	$28.0M-0.3%	$28.1M-9.2%	$30.9M
Current Assets	$31.8M+79.9%	$17.7M-28.8%	$24.8M+20.1%	$20.7M+41.5%	$14.6M+4.3%	$14.0M-0.5%	$14.1M-15.4%	$16.6M
Cash & Equivalents	$18.5M+218.0%	$5.8M-69.2%	$18.8M+3.7%	$18.2M+46.7%	$12.4M+3.8%	$11.9M+0.4%	$11.9M-7.5%	$12.9M
Inventory	$8.4M+23.5%	$6.8M+70.7%	$4.0M+220.4%	$1.2M+169.4%	$462K-29.2%	$653K-52.9%	$1.4M-26.1%	$1.9M
Accounts Receivable	$1.9M-25.4%	$2.5M+28.9%	$2.0M+79.4%	$1.1M-21.1%	$1.4M+31.8%	$1.1M+69.2%	$625K-55.0%	$1.4M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$8.1M-18.6%	$10.0M+44.7%	$6.9M+14.3%	$6.0M+87.2%	$3.2M+24.1%	$2.6M+1.0%	$2.6M+39.5%	$1.8M
Current Liabilities	$6.3M-21.7%	$8.0M+69.5%	$4.7M+17.8%	$4.0M+220.0%	$1.3M+38.2%	$906K+1.0%	$897K-29.9%	$1.3M
Long-Term Debt	$93K-27.0%	$128K-21.1%	$162K-17.3%	$195K-25.4%	$262K	$0	$0-100.0%	$180K
Total Equity	$71.8M+91.3%	$37.5M+15.1%	$32.6M+14.0%	$28.6M+11.3%	$25.7M+1.2%	$25.4M-0.5%	$25.5M-12.2%	$29.1M
Retained Earnings	-$45.2M-11.8%	-$40.4M+0.4%	-$40.6M+1.3%	-$41.1M-4.1%	-$39.5M+0.5%	-$39.7M-0.8%	-$39.4M-9.9%	-$35.9M

UAMY Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$2.2M+146.7%	-$4.8M-1805.5%	-$249K+89.7%	-$2.4M-86.2%	-$1.3M-11398.6%	-$11K
Capital Expenditures	$431K-71.8%	$1.5M-11.5%	$1.7M+166.4%	$648K+166.6%	$243K-69.3%	$793K
Free Cash Flow	$1.8M+128.5%	-$6.3M-217.8%	-$2.0M+35.8%	-$3.1M-98.8%	-$1.5M-92.6%	-$804K
Investing Cash Flow	-$42K+96.9%	-$1.3M+24.9%	-$1.8M-173.4%	-$653K-168.7%	-$243K+38.1%	-$393K
Financing Cash Flow	$4.1M+486.3%	-$1.1M-300.1%	-$268K-101.1%	$23.8M+1033.4%	$2.1M+353.1%	$463K
Dividends Paid	$0-100.0%	$788K	$0	N/A	N/A	N/A
Share Buybacks	N/A	$0-100.0%	$203K	$0	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$3.9M-515.5%	-$628K+63.7%	-$1.7M-246.8%	$1.2M+108.2%	$566K+770.3%	$65K+101.6%	-$4.1M-957.7%	$473K
Capital Expenditures	$8.7M+32.8%	$6.5M+657.3%	$863K+315.6%	$208K+111.8%	$98K+85.9%	$53K-72.4%	$191K+34.8%	$142K
Free Cash Flow	-$12.5M-75.1%	-$7.2M-176.2%	-$2.6M-367.0%	$971K+107.4%	$468K+3700.0%	$12K+100.3%	-$4.2M-1383.3%	$331K
Investing Cash Flow	-$18.6M-12.6%	-$16.5M-1816.8%	-$862K-369.0%	-$184K-87.5%	-$98K-4725.6%	-$2K-101.1%	$178K+203.6%	-$172K
Financing Cash Flow	$35.1M+754.2%	$4.1M+29.9%	$3.2M-24.8%	$4.2M+23749.7%	-$18K+16.3%	-$21K+90.0%	-$214K-116.2%	$1.3M
Dividends Paid	N/A	N/A	N/A	$0	$0	$0	$0	$0
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

UAMY Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	23.2%+61.7pp	-38.5%-56.5pp	18.1%+7.2pp	10.8%+6.9pp	3.9%+13.8pp	-9.9%
Operating Margin	-16.0%+65.3pp	-81.3%-84.5pp	3.1%+11.7pp	-8.5%+54.6pp	-63.1%-17.7pp	-45.4%
Net Margin	-11.6%+61.4pp	-73.0%-76.9pp	3.9%+4.7pp	-0.8%+62.0pp	-62.8%-18.4pp	-44.4%
Return on Equity	N/A	N/A	1.4%	N/A	N/A	N/A
Return on Assets	-5.0%+17.6pp	-22.6%-23.8pp	1.2%+1.4pp	-0.2%+24.5pp	-24.7%+2.1pp	-26.8%
Current Ratio	5.16-10.5	15.68+5.9	9.74-1.6	11.38+11.0	0.40+0.1	0.32
Debt-to-Equity	0.010.0	0.000.0	0.010.0	0.010.0	0.000.0	0.01
FCF Margin	12.0%+84.2pp	-72.2%-54.3pp	-17.9%+21.9pp	-39.8%-10.2pp	-29.6%-19.9pp	-9.7%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	23.1%-3.8pp	27.0%-6.9pp	33.9%+12.5pp	21.4%-12.8pp	34.1%+14.9pp	19.2%+222.8pp	-203.6%-216.1pp	12.5%
Operating Margin	-56.5%-56.7pp	0.2%-4.9pp	5.1%+24.4pp	-19.3%-20.8pp	1.5%+16.8pp	-15.3%+290.6pp	-305.9%-288.3pp	-17.6%
Net Margin	-54.9%-56.7pp	1.7%-6.1pp	7.8%+23.5pp	-15.7%-21.2pp	5.5%+16.1pp	-10.5%+154.8pp	-165.3%-85.6pp	-79.7%
Return on Equity	N/A	0.5%-1.2pp	1.7%	N/A	0.8%	N/A	N/A	N/A
Return on Assets	-6.0%-6.4pp	0.4%-1.0pp	1.4%+3.9pp	-2.5%-3.3pp	0.7%+1.8pp	-1.1%+11.5pp	-12.7%-7.4pp	-5.3%
Current Ratio	5.08+2.9	2.21-3.1	5.26+0.1	5.16-6.5	11.67-3.8	15.46-0.2	15.68+2.7	12.99
Debt-to-Equity	0.000.0	0.000.0	0.010.0	0.010.0	0.01+0.0	0.000.0	0.000.0	0.01
FCF Margin	-144.1%-76.1pp	-68.0%-31.0pp	-37.0%-54.3pp	17.2%+4.5pp	12.8%+12.4pp	0.4%+197.5pp	-197.1%-213.2pp	16.0%

Similar Companies

Sigma Lithium Corporation SGML

$1.5B

Standard Lithium SLI

$981.7M

Lithium Argentina AG LAR

$1.1B

Nexa Resources NEXA

$1.6B

Frequently Asked Questions

What is United States Antimony's annual revenue?

United States Antimony (UAMY) reported $14.9M in total revenue for fiscal year 2024. This represents a 71.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is United States Antimony's revenue growing?

United States Antimony (UAMY) revenue grew by 71.8% year-over-year, from $8.7M to $14.9M in fiscal year 2024.

Is United States Antimony profitable?

No, United States Antimony (UAMY) reported a net income of -$1.7M in fiscal year 2024, with a net profit margin of -11.6%.

What is United States Antimony's earnings per share (EPS)?

United States Antimony (UAMY) reported diluted earnings per share of $-0.02 for fiscal year 2024. This represents a 66.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is United States Antimony's EBITDA?

United States Antimony (UAMY) had EBITDA of -$1.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does United States Antimony have?

As of fiscal year 2024, United States Antimony (UAMY) had $18.2M in cash and equivalents against $195K in long-term debt.

What is United States Antimony's gross margin?

United States Antimony (UAMY) had a gross margin of 23.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is United States Antimony's operating margin?

United States Antimony (UAMY) had an operating margin of -16.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is United States Antimony's net profit margin?

United States Antimony (UAMY) had a net profit margin of -11.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is United States Antimony's free cash flow?

United States Antimony (UAMY) generated $1.8M in free cash flow during fiscal year 2024. This represents a 128.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is United States Antimony's operating cash flow?

United States Antimony (UAMY) generated $2.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are United States Antimony's total assets?

United States Antimony (UAMY) had $34.6M in total assets as of fiscal year 2024, including both current and long-term assets.

What are United States Antimony's capital expenditures?

United States Antimony (UAMY) invested $431K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does United States Antimony have outstanding?

United States Antimony (UAMY) had 113M shares outstanding as of fiscal year 2024.

What is United States Antimony's current ratio?

United States Antimony (UAMY) had a current ratio of 5.16 as of fiscal year 2024, which is generally considered healthy.

What is United States Antimony's debt-to-equity ratio?

United States Antimony (UAMY) had a debt-to-equity ratio of 0.01 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is United States Antimony's return on assets (ROA)?

United States Antimony (UAMY) had a return on assets of -5.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is United States Antimony's Piotroski F-Score?

United States Antimony (UAMY) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are United States Antimony's earnings high quality?

United States Antimony (UAMY) has an earnings quality ratio of -1.28x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is United States Antimony?

United States Antimony (UAMY) scores 72 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.